Nicotine Transdermal System Patch Patch, Extended Release
NDC Package 68001-699-88
Package Information
Nicotine Transdermal System Patch patches is if you are under 18 years of age, ask a doctor before usebefore using this product, read the enclosed self-help guide for complete directions and other informationbegin using the patch on your quit dayif you smoke more than 10 cigarettes per day, use the following schedule below: if you smoke 10 or less cigarettes per day, start with Step 2 for 6 weeks, then Step 3 for 2 weeks apply one new patch every 24 hours on skin that is dry, clean and hairlessremove backing from patch and immediately press onto skin. This formulation utilizes a patch, extended release delivery system. Marketed by Bluepoint Laboratories, this product is identified by NDC 68001-699 and is authorized under FDA application NDA020076.
Identification & Billing
- RxCUI: 198029 - nicotine 14 MG/Day 24HR Transdermal System
- RxCUI: 198029 - 24 HR nicotine 0.583 MG/HR Transdermal System
- RxCUI: 198029 - nicotine 0.583 MG/HR 24HR Transdermal Patch
- RxCUI: 198029 - nicotine 14 MG per 24HR 1 Day Transdermal Patch
- RxCUI: 198030 - nicotine 21 MG/Day 24HR Transdermal System
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68001 - Bluepoint Laboratories
- 68001-699 - Nicotine Transdermal System Patch
- 68001-699-88 - 7 PATCH in 1 CARTON / 24 h in 1 PATCH
- 68001-699 - Nicotine Transdermal System Patch
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68001-699). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68001-699-88 identifies a specific commercial package of 7 patch in 1 carton / 24 h in 1 patch of Nicotine Transdermal System Patch Step 1, a human over the counter drug labeled by Bluepoint Laboratories. This patch, extended release is formulated for transdermal use and contains nicotine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bluepoint Laboratories on May 28, 2026. The current certification is valid through December 31, 2027.
How is this Bluepoint Laboratories product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68001069988. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 7 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.